![Equivalent dosing of irbesartan, valsartan, and losartan identified through formulary switch at a Veterans Affairs medical center Equivalent dosing of irbesartan, valsartan, and losartan identified through formulary switch at a Veterans Affairs medical center](https://cdn.sanity.io/images/0vv8moc6/formularywatch/e37714a0e388feff569f7e91e3c258dd9a03a8e8-200x128.jpg)
Equivalent dosing of irbesartan, valsartan, and losartan identified through formulary switch at a Veterans Affairs medical center
![Differential Sex-Specific Effects of Angiotensin-Converting Enzyme Inhibition and Angiotensin Receptor Blocker Therapy on Arterial Function in Hypertension: CALIBREX Trial | Hypertension Differential Sex-Specific Effects of Angiotensin-Converting Enzyme Inhibition and Angiotensin Receptor Blocker Therapy on Arterial Function in Hypertension: CALIBREX Trial | Hypertension](https://www.ahajournals.org/cms/asset/0ef8273d-3a19-4f72-9574-cc4ad16fadd2/hypertensionaha.122.19105.fig03.jpg)
Differential Sex-Specific Effects of Angiotensin-Converting Enzyme Inhibition and Angiotensin Receptor Blocker Therapy on Arterial Function in Hypertension: CALIBREX Trial | Hypertension
![Equivalent dosing of irbesartan, valsartan, and losartan identified through formulary switch at a Veterans Affairs medical center Equivalent dosing of irbesartan, valsartan, and losartan identified through formulary switch at a Veterans Affairs medical center](https://cdn.sanity.io/images/0vv8moc6/formularywatch/2116722128441a75af7a059b15b119a151795570-187x150.jpg)
Equivalent dosing of irbesartan, valsartan, and losartan identified through formulary switch at a Veterans Affairs medical center
![From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5) - ScienceDirect From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109719354567-fx1.jpg)
From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5) - ScienceDirect
![Angiotensin-II receptor blockers: benefits beyond blood pressure reduction? | Journal of Human Hypertension Angiotensin-II receptor blockers: benefits beyond blood pressure reduction? | Journal of Human Hypertension](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.jhh.1001831/MediaObjects/41371_2005_Article_BF1001831_Fig1_HTML.jpg)